Three on UCSF Faculty Elected to Institute of Medicine
Three UCSF faculty members are among the 70 newly elected members of the Institute of Medicine, considered one of the highest honors in the health sciences.
![](/sites/default/files/styles/news_card__image/public/field/image/news/cooke_molly_3.jpg)
University of California San Francisco
Give to UCSFThree UCSF faculty members are among the 70 newly elected members of the Institute of Medicine, considered one of the highest honors in the health sciences.
The UCSF-affiliated Ernest Gallo Clinic and Research Center has issued a second round of grants to accelerate the discovery and development of new medications to treat alcohol and substance abuse in the context of post-traumatic stress and combat injury.
Newly appointed University of California President Janet Napolitano shared a letter to the UC community.
In recent years, studies have reported inconsistent findings regarding whether calcium supplements used to prevent fractures increase the risk of heart attack.
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
The Science of Staying Younger Longer is a by-invitation symposium and panel discussion highlighting advances in scientific understanding of the biological underpinnings of aging and ideas for how to slow down age-associated disease and decline.
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.
A team of UCSF researchers developing cell-based therapies for acute respiratory distress syndrome benefited from advisors who helped identify gaps in their development plan.
A UCSF opthamologist and bioengineer are collaborating to develop a tiny, flexible, implantable film that's able to deliver conventional medicines and also complex antibody-based drugs to treat eye diseases.
Ruben Rathnasingham, PhD, associate director of Early Translational Research at UCSF's Clinical and Translational Science Institute, is leading the team responsible for LaunchPad. In this Q&A, he discusses the project and how it can benefit researchers.
Teams of scientists at UCSF are collaborating to build upon existing imaging techniques and find new ways to monitor diseases using creative applications of emerging technologies.
A team from UCSF was one of six winners of the worldwide OpenIDEO/Mayo Clinic Challenge that sought to answer the question, “How might we all maintain well-being and thrive as we age?”